USA - NASDAQ:SNYR - US87165D2080 - Common Stock
The current stock price of SNYR is 2.11 USD. In the past month the price decreased by -16.44%. In the past year, price decreased by -63.62%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| KVUE | KENVUE INC | 15.18 | 31.17B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 51.24 | 31.02B | ||
| ELF | ELF BEAUTY INC | 23.56 | 4.13B | ||
| BRBR | BELLRING BRANDS INC | 11.81 | 3.23B | ||
| COTY | COTY INC-CL A | 17.63 | 2.93B | ||
| IPAR | INTERPARFUMS INC | 16 | 2.69B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.01 | 826.99M | ||
| OLPX | OLAPLEX HOLDINGS INC | 12.75 | 680.42M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 6.89 | 470.75M | ||
| NATR | NATURES SUNSHINE PRODS INC | 21.84 | 362.15M | ||
| USNA | USANA HEALTH SCIENCES INC | 9.65 | 345.67M | ||
| HNST | HONEST CO INC/THE | 40.5 | 270.39M |
Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company is headquartered in Westbrook, Maine and currently employs 21 full-time employees. The company went IPO on 2013-11-08. The firm is the provider of consumer healthcare, beauty, and lifestyle products. The Company’s brand portfolio consists of FOCUSfactor and Flat Tummy. FOCUSfactor is a brain health supplement brand. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. The company has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
SYNERGY CHC CORP
865 Spring St
Westbrook MAINE US
Employees: 21
Phone: 16159399004
Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company is headquartered in Westbrook, Maine and currently employs 21 full-time employees. The company went IPO on 2013-11-08. The firm is the provider of consumer healthcare, beauty, and lifestyle products. The Company’s brand portfolio consists of FOCUSfactor and Flat Tummy. FOCUSfactor is a brain health supplement brand. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. The company has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
The current stock price of SNYR is 2.11 USD. The price increased by 0.96% in the last trading session.
SNYR does not pay a dividend.
SNYR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
SYNERGY CHC CORP (SNYR) has a market capitalization of 23.61M USD. This makes SNYR a Nano Cap stock.
SYNERGY CHC CORP (SNYR) will report earnings on 2026-03-30.
ChartMill assigns a fundamental rating of 5 / 10 to SNYR. Both the profitability and the financial health of SNYR get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months SNYR reported a non-GAAP Earnings per Share(EPS) of 0.38. The EPS decreased by -67.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.61% | ||
| ROA | 16.42% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
7 analysts have analysed SNYR and the average price target is 7.14 USD. This implies a price increase of 238.39% is expected in the next year compared to the current price of 2.11.
For the next year, analysts expect an EPS growth of 13.89% and a revenue growth 23.04% for SNYR